Article 96. Stages of bioequivalence trial of a drug and drugs subject to bioequivalence trial
Law 105/2016/QH13 — Luật Dược số 105/2016/QH13
Bioequivalence trial of drugs
1. The bioequivalence trial of a drug includes the following stages:
a/ The clinical research stage, which is the stage of testing a comparative drug and the drug put for bioequivalence trial, which have been confirmed to satisfy safety and efficacy requirements, to compare their bioavailability on a volunteer;
b/ The human biofluid analysis stage, which is the stage of analyzing and identifying the concentrations of the comparative drugs and the drug put for bioequivalence trial in the volunteer’s bio-specimens, after they are used in the clinical research stage, in order to compare their bioavailability and prove their bioequivalence.
2. A generic drug shall be put for bioequivalence trial when it contains a pharmaceutical ingredient and has a form of preparation on the list of pharmaceutical ingredients and forms of preparation subject to bioequivalence trial issued by the Minister of Health.
Article 96, Law 105/2016/QH13